Sirnaomics Ltd. (HKG:2257)
Hong Kong · Delayed Price · Currency is HKD 4.520
-0.010 (-0.22%)
Jul 21, 2026, 4:08 PM HKT
Sirnaomics Market Cap
Sirnaomics has a market cap or net worth of 492.22 million as of July 21, 2026. Its market cap has decreased by -26.41% in one year.
Market Cap
492.22M
Enterprise Value
346.03M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.52
ChartMarket Cap Chart
Since December 30, 2021, Sirnaomics's market cap has decreased from 6.86B to 492.22M, a decrease of -92.83%. That is a compound annual growth rate of -43.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 492.22M | -39.68% |
| Dec 31, 2025 | 816.08M | 126.04% |
| Dec 31, 2024 | 361.03M | -88.38% |
| Dec 29, 2023 | 3.11B | -38.75% |
| Dec 30, 2022 | 5.07B | -36.82% |
| Dec 31, 2021 | 8.03B | 17.07% |
| Dec 30, 2021 | 6.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cutia Therapeutics | 948.39M |
| Kintor Pharmaceutical | 834.54M |
| Wuhan YZY Biopharma | 715.30M |
| Brii Biosciences | 714.59M |
| JW (Cayman) Therapeutics Co. | 698.14M |
| Shanghai Bio-heart Biological Technology | 676.70M |
| 3D Medicines | 541.03M |
| Uni-Bio Science Group | 489.64M |